Pharmacological activation of SERCA2a SUMOylation improves cardiac function and pathology in models of Duchenne muscular dystrophy

被引：0
|
作者：
Oh, J. [1 ]
Lee, P. [1 ]
Watanabe, S. [1 ]
DeVita, R. [1 ]
Hajjar, R. [1 ]
Kho, C. [1 ]
Lee, A. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.428
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.314
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [1] SERCA2a overexpression improves muscle function in a canine Duchenne muscular dystrophy model
    Kodippili, Kasun
    Hakim, Chady H.
    Burke, Matthew J.
    Yue, Yongping
    Teixeira, James A.
    Zhang, Keqing
    Yao, Gang
    Babu, Gopal J.
    Herzog, Roland W.
    Duan, Dongsheng
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
  • [2] Muscle Pathology Associated With Cardiac Function in Duchenne Muscular Dystrophy
    Yoon, Jin A.
    Lee, Heirim
    Lee, In Sook
    Song, You Seon
    Lee, Byeong-Ju
    Kim, Soo-Yeon
    Shin, Yong Beom
    ANNALS OF REHABILITATION MEDICINE-ARM, 2024, 48 (06): : 405 - 412
  • [3] Cardiac atrial pathology in Duchenne muscular dystrophy
    Greiner, Eleanor
    Breaux, Andrea
    Kasten, Jennifer
    Seo, Jangdong
    Ollberding, Nicholas J.
    Spar, David
    Ryan, Thomas D.
    Lang, Sean M.
    Tian, Cuixia
    Sawnani, Hemant
    Villa, Chet R.
    MUSCLE & NERVE, 2024, 69 (05) : 572 - 579
  • [4] Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy
    Wasala, Nalinda B.
    Yue, Yongping
    Lostal, William
    Wasala, Lakmini P.
    Niranjan, Nandita
    Hajjar, Roger J.
    Babu, Gopal J.
    Duan, Dongsheng
    MOLECULAR THERAPY, 2020, 28 (03) : 845 - 854
  • [5] Chloroquine decreases cardiac fibrosis and improves cardiac function in a mouse model of Duchenne muscular dystrophy
    Hirata, Takuya
    Baba, Shiro
    Akagi, Kentaro
    Matsuda, Koichi
    Umeda, Katsutsugu
    Adachi, Souichi
    Heike, Toshio
    Takita, Junko
    PLOS ONE, 2024, 19 (01):
  • [6] Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy
    L.W. Markham
    R.L. Spicer
    P.R. Khoury
    B.L. Wong
    K.D. Mathews
    L.H. Cripe
    Pediatric Cardiology, 2005, 26 : 768 - 771
  • [7] Steroid therapy and cardiac function in Duchenne muscular dystrophy
    Markham, LW
    Spicer, RL
    Khoury, PR
    Wong, BL
    Mathews, KD
    Cripe, LH
    PEDIATRIC CARDIOLOGY, 2005, 26 (06) : 768 - 771
  • [8] Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
    Changwon Kho
    Ahyoung Lee
    Dongtak Jeong
    Jae Gyun Oh
    Przemek A. Gorski
    Kenneth Fish
    Roberto Sanchez
    Robert J. DeVita
    Geir Christensen
    Russell Dahl
    Roger J. Hajjar
    Nature Communications, 6
  • [9] Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
    Kho, Changwon
    Lee, Ahyoung
    Jeong, Dongtak
    Oh, Jae Gyun
    Gorski, Przemek A.
    Fish, Kenneth
    Sanchez, Roberto
    DeVita, Robert J.
    Christensen, Geir
    Dahl, Russell
    Hajjar, Roger J.
    NATURE COMMUNICATIONS, 2015, 6
  • [10] SERCA2a overexpression improves cardiac performance in diabetic mice
    Trost, SU
    Bluhm, WF
    Karlon, WJ
    Swanson, E
    Dillmann, WH
    CIRCULATION, 1998, 98 (17) : 140 - 140
12345